Latest News

Eight growth medicines now each exceed $1 billion in annual sales.

Revenue surged 29% year-over-year to $277M, with data center sales more than doubling.

Smokeable products drive EPS growth as discount segment gains amid economic pressures.

Record $63.7B backlog signals robust demand across power and utility markets.

Industrial sales momentum exceeded expectations as commercial vehicle segment surged 23%.

BRINSUPRI revenue surged to $400.1 million, driving 268% total revenue growth year-over-year.

EyeQ shipments grew 3% despite production headwinds, SuperVision exceeded targets.

Subsea segment margins hit record highs as offshore activity surges.

Record margins and backlog surge as AI chip demand drives semiconductor materials growth.

Memory costs surge to 10% of machine expenses as Xerox cuts guidance and suspends dividends.

Self-pay net additions returned positive as digital advertising surged 20% in podcasting.

Okta is the leading independent identity platform with improving profitability and expanding enterprise deals. UiPath is posting steady growth as AI expands automation demand, but revenue acceleration is still unproven.

In a Berkshire Hathaway letter over a decade ago, Buffett made it clear which fund he likes.

Organic growth slowed, but management accelerates cost cuts to meet full-year targets.

Operating income rose 14% as insurance premiums grew 9% amid market headwinds.

Gold prices surged 23% year-over-year, lifting earnings despite production headwinds.

LTL yield surged 3.6% as volume gains and pricing strength drove record operating income.

Revenue jumped 52% YoY to $32.6M, beating guidance with record margins.

Management took $800M in impairments and sold $1B legacy office loans.

Pricing power and automation drive margin expansion despite consumer spending headwinds.

Record portfolio occupancy and pricing power drive FFO growth and capital recycling strategy.

These biotechs’ valuations are through the roof.

Sterling’s revenue more than doubled on data center demand, and it raised guidance. But it burned through signed contracts faster than it added them. Here’s what that means for the growth story.

NXP Semiconductors beat Q3 estimates with wider margins, a $5 billion buyback increase and strong cash flow, though cautious Q4 guidance sent shares lower despite analysts' 20% upside consensus.

Revenue rose 12% as experiential assets outperformed and investment accelerated.